EQUASHIELD PRODUCTS NOW AVAILABLE IN KENYA VIA MERCURY HEALTHCARE SOLUTIONS
MERCURY HEALTHCARE SOLUTIONS AND EQUASHIELD SIGN EXCLUSIVE AGREEMENT TO INCREASE HOSPITAL WORKER SAFETY IN KENYA
Mercury Healthcare to offer closed system transfer devices and provide market education on chemo safe handling through Chemo Safe Project, increasing knowledge and training for Kenyan healthcare workers
PORT WASHINGTON, New York – March 18, 2019 Equashield (http://www.equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced today a new exclusive partnership with Mercury Healthcare Solutions to distribute its manual and automated solutions for safe compounding and administration of hazardous drugs.
“Access to chemotherapy treatment is growing in Kenya, and with that is increasing education and awareness of the health risks to professionals handling hazardous drugs. Conversations, training and implementation of safety standards are becoming a regular part of the discussion among healthcare stakeholders in Kenya,” explained Dr. Wairimu Mbogo, Head of Commercial Operations for Mercury Healthcare Solutions. “With this growth in hazardous drug handling in Kenya, Equashield is committed to supporting Kenyan oncology units and compounding pharmacies by offering its CSTDs to the market.”
Mercury Healthcare Solutions will begin distributing Equashield’s flagship CSTD, EQUASHIELD, to Kenyan healthcare facilities, with plans to expand throughout East Africa. “Dr. Mbogo and her team at Mercury Healthcare Solutions are ideal partners for us in this region, showing a true commitment to providing the equipment necessary to deliver healthcare safely and effectively,” said Adi Shor, VP of Sales ROW for Equashield. “Mercury is a respected leader in Kenya, and we are confident that we will see our partners drive positive change towards increased safety in the burgeoning oncology market.” Mercury Healthcare Solutions is supporting the Chemo Safe Project initiated by the American Cancer Society in partnership with the Kenyan Ministry of Health and Kenya Hospices and Palliative Care Association. The year-long program will provide training to healthcare professionals, focusing on the lifecycle of chemotherapy delivery. The program will cover topics ranging from logistics to preparation, administration and disposal of hazardous drugs, with the goal of increasing the quality of care and safety for both healthcare professionals and patients.
About Mercury Healthcare Solutions
Mercury Healthcare Solutions is a leading Pharmaceutical and Healthcare distributor based in Nairobi, Kenya, covering the East Africa market. Its focus is to provide easy access to Oncology and Specialty products, services and solutions for healthcare professionals at an affordable cost. Leading Mercury Healthcare Solutions is a qualified team committed to excellence, offering the very best healthcare solutions to stakeholders within the healthcare space.
For more information, visit: http://www.mercuryhealthcare.co.ke
Equashield is a leading provider of manual and automated solutions for the compounding and administration of hazardous drugs. Equashield’s product suite includes EQUASHIELD II, its flagship Closed System Transfer Device (CSTD), and EQUASHIELD® Pro, the first ever closed system-enabled Automated Pharmacy Compounding System. Equashield’s CSTD is clinically-proven to protect healthcare professionals from hazardous drug exposure. EQUASHIELD II covers more routes of exposure than alternative systems and has passed the proposed 2015 alcohol vapor containment protocol from NIOSH, confirming that it can contain the harshest vapors & emissions. Studies have shown Equashield’s CSTD as faster to deploy and easier to use than competing systems. Used by hundreds of hospitals and clinics around the world, EQUASHIELD II is CE marked and substantiated by the FDA for preventing microbial ingress for up to seven days.
For more information: http://www.equashield.com